NCT05088174View on ClinicalTrials.gov

A Trial of Hetrombopag in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

October 22, 2020

Study Completion Date

October 22, 2020

Conditions
Sever Aplastic Anaemia
Interventions
DRUG

Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule

"Drug:~Hetrombopag Olamine Tablet Ciclosporin Soft Capsule"

Trial Locations (1)

610041

West China Second University Hospital Ethics Committee, Chengdu

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05088174 - A Trial of Hetrombopag in Healthy Subjects | Biotech Hunter | Biotech Hunter